Portable air disinfection device rapidly kills coronavirusBuildings COVID-19 Updates
Health Canada has approved it as a Class 1 medical device.
Toronto-based Flat Iron Building Group has created a new business, Flairon Microclimates, to distribute Europe’s Novaerus portable air disinfection devices in Canada. The technology has been shown to kill 99.9% of MS2 Bacteriophage, a surrogate for the novel coronavirus that causes COVID-19.
The hospital-grade technology promises to rapidly kill airborne coronaviruses to make the air in high-density office buildings, including their elevators, safer as tenants and employees return to their workplaces.
“As Canadian businesses seek new ways to adapt to the ongoing disruption created by the global pandemic, the Novaerus device revolutionizes the return to work,” says Daniel De Monte, Flat Iron’s CEO. “What makes it stand out are its ability to kill the virus on the spot, its ease of use and its portability.”
The device, which uses ultra-low-energy plasma technology for infection control, was originally introduced to Canada in 2019 for health-care facilities requiring high air purity for intensive care units (ICUs) and in-vitro fertilization labs and Health Canada has approved it as a Class 1 medical device.
“We now know disinfecting the air is a critical step in reducing the transmission of airborne viruses,” says Julie Phillips, Flat Iron’s president.